The rate of -Blocker prescription within nine months after discharge for acute myocardial infarction (AMI) patients (disease-specific indicator)
The National Health Insurance Administration (NHIA) has selected evidence-based medical indicators to be made public in order to strengthen the quality of medical care for patients with myocardial infarction. These indicators serve as references for relevant diseases when seeking medical care or assessing the quality of health care. The public indicators are divided into three categories based on the treatment period and quality aspects, including inpatient process assessment, assessment of continuous medication after discharge, and outcome assessment. This includes the ratio of AMI patients undergoing LDL cholesterol testing during hospitalization, medication ratios for AMI patients during hospitalization and at three, six, and nine months after discharge, emergency room revisit rates within three days after discharge for the same primary diagnosis or related condition, and unplanned readmission rates within fourteen days after discharge for the same primary diagnosis or related condition.
Data fields
Year、Healthcare facility code、Name of medical institution、Special Contract Category、The number of cases that returned to the same hospital outpatient clinic within 9 months after discharge to receive β-Blockers、Discharged AMI case_ Excluded COPD, Asthma, Bradycardia, Hypotension、The ratio of β-Blocker administration within 9 months after discharge.、The number of reporting physicians、Average age of patients、The number of seriously ill patients、Serious illness and injury rate of patients、County or city、Township
Contact person
陳綉琴 (02-27065866#3006)
Update frequency
Every June
License
Open Government Data License, version 1.0
Charge
free
Publish date
2015-11-23
Dataset type
System programming interface
Updated time
2025-02-04 07:10
Topic
Other
Service category
Dataset Category
Data archives
Keyword
Medical qualityAcute myocardial infarction.AMIB-type blockerBeta-blocker
Note
Authorization explanation URL: https://data.nhi.gov.tw/Banner/DevelopGuide.aspxAPI documentation for OAS standard: https://data.nhi.gov.tw/openapi.jsonThis dataset resource ID: A21030000I-E32016-001
Related datasets
- The medication rate for beta-blockers given to acute myocardial infarction (AMI) patients within three months of discharge (Disease-specific Measure)
- Acute Myocardial Infarction (AMI) patients were given medication within six months after discharge - Beta-Blocker (disease-specific indicator).
- Acute myocardial infarction (AMI) patients receiving medication during hospitalization rates - Beta blockers (disease-specific indicator).
- The rate of medication given within six months after discharge for patients with acute myocardial infarction (AMI) - aspirin (disease-specific indicator)
- Acute myocardial infarction (AMI) patient medication rate during hospitalization - Aspirin (Disease-specific indicator)
Applications
No available applications